Companies
Hetero launches COVID-19 drug Favivir at Rs 59 per tablet
The product is available from July 29 at all retail medical outlets across the country and will be sold only on prescription, it said
Moderna to price COVID-19 vaccine at $50-$60 per course
Moderna’s proposed price would apply to the United States and other high-income countries
Reliance set to acquire Future Group's retail business for Rs 27,000 crore
Reliance’s existing retail operation already runs close to 12,000 stores in over 6,700 Indian towns and cities
Huawei is laying off 60-70% staff in India, cuts revenue target for 2020
Huawei is now targeting $350-$500 million in revenue for 2020, compared with roughly $700-800 million it was aiming earlier
Lupin, Granules recall 9,71,000 bottles of Metformin supplied to US
Hyderabad-based Granules India is recalling over 4.78 lakh bottles of the drug in 750 mg strength
Maharashtra FDA to buy remdesivir from Gujarat firm
State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency
Sun Pharma's Taro resolves multi-year investigations over generic drug pricing
Taro Pharmaceutical said that it is discussing a separate corporate integrity agreement with the department of health and human services
Pfizer, BioNTech reach $1.95 billion COVID-19 vaccine deal with US
The contract for 100 million doses of the vaccine amounts to a $39 price tag for what is likely to be a two-dose course of treatment
Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
India lockdown dents CocaCola sales in June quarter
Unit case volume declined 36 per cent driven by India and South Africa due to the impact of the coronavirus, said CocaCola